Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Chinese Patent Office
Fish and Richardson

Generated: March 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020789

« Back to Dashboard

NDA 020789 describes ZONEGRAN, which is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the ZONEGRAN profile page.

The generic ingredient in ZONEGRAN is zonisamide. There are eighteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 020789
Applicant:Sunovion Pharms Inc
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020789
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZONEGRAN zonisamide CAPSULE;ORAL 020789 NDA Concordia Pharmaceuticals Inc. 59212-680 N 59212-680-10
ZONEGRAN zonisamide CAPSULE;ORAL 020789 NDA Concordia Pharmaceuticals Inc. 59212-681 N 59212-681-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Mar 27, 2000TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Aug 22, 2003TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Aug 22, 2003TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
US Department of Justice
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.